November 21, 2014

A Daughter’s Plea to the Supreme Court: Let My Parents Keep Their Health Insurance
The Huffington Post – Nov. 20
While my dad was undergoing cancer treatment, doctors also delivered the terrible news that my mother's oral cancer had returned and that she would require surgery in August 2014. Thanks to her Obamacare coverage, my Mom was able to have the tumor removed by a specialist at the top-ranked Moffitt Cancer Center --all covered by her insurance. What could be so awful about a law that made all this happen for my parents?

Celgene Wins Rights To Moffitt’s Investigational MDS Therapy
BioProcess Online – Nov. 20
The Moffitt Cancer Center announced Monday that it has entered an exclusive licensing agreement with Celgene Corporation, which gives Celgene the exclusive rights to its novel, investigational therapy for Myelodysplastic Syndromes (MDS).

Creative Coping Improves Cancer Recovery
Ivanhoe Broadcast News via KSAT, ABC 12 (San Antonio, Texas) – Nov. 18
Jacob Gardinier Scott, MD, Radiation Oncologist of Moffitt Cancer Center says finding ways to cope can be helpful for patients. Doctor Scott explained, “I find that the people who are able to divert the focus back to something else, something important to them are the ones who even do better.”

Moffitt signs deal for experimental treatment
Business Observer – Nov. 18
Moffitt Cancer Center reached a licensing agreement with Celgene Corp. that gives the public company the exclusive rights to an investigational cancer treatment.

Should all medical professionals wear scrubs in public?
WTSP, 10 News – Nov. 18
Moffitt Cancer Center told 10 Investigates that it provides – and launders - scrubs for anyone who works in the operating room, endoscopy/procedures department, sterile processing department, or interventional radiology. Those individuals are not allowed to take the scrubs out of the hospital.

Chemotherapy Drug Reduces Resistance to Brain Tumor Therapy
Specialty Pharmacy Times – Nov. 18
“To make sure we are getting the ‘biggest bang for the buck,’ we needed to understand how the body was fighting the virus in the brain tumor so we can dampen its response and maximize the chance of cure,” Peter A. Forsyth, MD, chair of the Neuro-Oncology Department at Moffitt Cancer Center, said in a press release.

Melanoma shows improved regression with combination of PV-10 and checkpoint inhibitor
Medical News Today – Nov. 18
“The spirit of our study was to determine whether combining PV-10 with a checkpoint inhibitor would enhance the systematic immune responses of the initial injection of PV-10,” explains Shari Pilon-Thomas, the first author from Moffitt Cancer Center in Tampa, FL.

Check out wellness events to stay healthy
Orlando Sentinel – Nov. 18
Living With Advanced Cancer: 10 a.m.-11:30 a.m. First and third Fridays of the month. Moffitt Cancer Center in The Villages. Pre-registration is required. Call 800-227-2345.

Moffitt, Celgene pair on treatment for cancer that struck GMA host Robin Roberts
Tampa Bay Business Journal – Nov. 17
Moffitt Cancer Center has developed an experimental treatment for myelodysplastic syndromes, a type of blood cancer that affects Robin Roberts, host of ABC’s “Good Morning America.”

Sarasota Memorial unveils $1.5 million surgery robot, recruits leading surgeon
The Bradenton Herald – Nov. 17
Meredith, trained in surgical oncology at the Moffitt Cancer Center, will start next week. His expertise is using the robot to remove malignancies of the pancreas, liver, biliary tract and esophagus.

Oviedo 4th grader hopes to cure cancer, raises money for research
Sanford Herald – Nov. 17
Oviedo 4th grader, Sydney Galus, has credited her recent fundraising efforts to the many she knows or have been survivors of cancer, but also to her role model, a scientist with the Moffitt Cancer Center.

Dr. Patricia Judson: Please don’t let your child become my patient
The Tampa Tribune – Nov. 15
Patricia Judson, M.D., is in the Department of Women’s Oncology at Moffitt Cancer Center in Tampa. The Tampa Bay HPV Awareness & Action Coalition was formed in an effort to improve HPV vaccination rates.

The Ohio State and Moffitt Collaborate on ORIEN: Using Big Data to Accelerate Trials With a Cancer Research ‘Expressway’
The ASCO Post – Nov. 15
The Ohio State University Comprehensive Cancer Center and Moffitt Cancer Center have joined forces to create the Oncology Research Information Exchange Network (ORIEN), the largest collaboration of its kind designed to accelerate discoveries in cancer research. Members of this alliance of cancer centers will agree to use a common protocol and share data, primarily for research, that ultimately will lead to evidence-based decisions for clinical care. Patients are active participants.

Martine Extermann, MD, PhD, Honored at the International Society of Geriatric Oncology’s Annual Meeting in Portugal
The ASCO Post – Nov. 15
Martine Extermann, MD, PhD, Senior Member of the Senior Adult Oncology and Health Outcomes & Behavior Programs at Moffitt Cancer Center, was the recipient of the 2014 Paul Calabresi Award.

Conclusion: Improving Outcomes in Melanoma
OncLive – Nov. 14
Jeffrey S. Weber, MD, PhD,Director, Donald A. Adam Comprehensive Melanoma Research Center, H. Lee Moffitt Cancer Center and Research Institute

Bay News 9 – Nov. 12
It’s being tested right here in the Bay area at Moffitt Cancer Center.


Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.